NOTVQ
Inotiv, Inc.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
470,990
P/E Ratio
—
EPS
$-2.48
Beta
3.92
52W High
$0.33
52W Low
$0.01
50-Day MA
$0.17
200-Day MA
$0.59
Dividend Yield
—
Profit Margin
-17.10%
Forward P/E
3.72
PEG Ratio
—
About Inotiv, Inc.
Inotiv, Inc. (NOTVQ) is a leading preclinical contract research organization specializing in drug development and safety assessment services for the biotech and pharmaceutical industries. The company offers a comprehensive range of solutions, including nonclinical imaging, pharmacology, and toxicology, to support the development of new therapeutics. Driven by innovation and a commitment to scientific excellence, Inotiv leverages advanced technologies and a highly skilled workforce to deliver valuable insights and data that facilitate the drug discovery process. With a growing portfolio of services, Inotiv is well-positioned to capitalize on the increasing demand for outsourcing in the life sciences sector.
Fundamentals
| Revenue (TTM) | $507.36M |
| Gross Profit (TTM) | $116.41M |
| EBITDA | $8.56M |
| Operating Margin | -16.00% |
| Return on Equity | -74.10% |
| Return on Assets | -4.02% |
| Revenue/Share (TTM) | $14.73 |
| Book Value | $2.21 |
| Price-to-Book | 0.01 |
| Price-to-Sales (TTM) | 0.00 |
| EV/Revenue | 0.932 |
| EV/EBITDA | 68.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -5.40% |
| Shares Outstanding | $34.89M |
| Float | $32.62M |
| % Insiders | 8.63% |
| % Institutions | 13.79% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
More HEALTHCARE Stocks
Data last updated: 7/9/2026